Herbal Monograph
White horehound
Marrubium vulgare L.
Lamiaceae (Mint family)
Ancient bitter expectorant — clears congested lungs and ignites sluggish digestion through 3,500 years of continuous use
Overview
Plant Description
Erect, bushy, woolly perennial, 30-60 cm tall. Stems square (Lamiaceae), branching from the base, densely covered with white, woolly, stellate hairs giving the plant its characteristic hoary (white-frosted) appearance — the common name 'horehound' derives from Old English 'har hune' (hoary plant). Leaves opposite, petiolate, broadly ovate to orbicular, 2-5 cm, deeply wrinkled (rugose) with crenate margins, grey-green above and densely white-tomentose below. Flowers small, white, bilabiate, borne in dense axillary whorls (verticillasters) at each node along the upper stem. Calyx with 10 hooked teeth that become rigid in fruit, aiding seed dispersal by clinging to animal fur. Nutlets smooth, ovoid, brown. The whole plant has a distinctive musky, somewhat bitter odor. Taste is intensely bitter, which is central to its medicinal action.
Habitat
Dry, disturbed soils, waste ground, roadsides, pastures, and field margins. Prefers well-drained, sandy or rocky soils in full sun. Drought-tolerant. Common in Mediterranean climates and semi-arid regions. Does not tolerate waterlogged soils.
Distribution
Native to Europe, North Africa, and western Asia (from the Canary Islands and Mediterranean basin through the Middle East to Central Asia). Widely naturalized in the Americas, Australia, and South Africa. In North America, established throughout the western and central United States. Declared a noxious weed in Australia and parts of the western US due to aggressive colonization of degraded pastureland.
Parts Used
Aerial parts (Marrubii herba)
Preferred: Infusion (covered) for acute respiratory conditions; tincture or syrup for chronic use; lozenges/candy as a traditional cough remedy
The aerial parts harvested during flowering are the recognized medicinal portion in all major pharmacopeias (European Pharmacopoeia, German Commission E, ESCOP). The leaves contain the highest concentration of marrubiin. Fresh juice was historically used in Eclectic practice but dried herb is standard in modern use. The European Pharmacopoeia specifies a minimum of 0.7% marrubiin content for Marrubii herba.
Key Constituents
Diterpene lactones (labdane type)
Marrubiin is the most important single constituent and the basis for horehound's primary clinical applications: expectorant (reflex mechanism via gastric stimulation → vagal-mediated bronchial secretion) and bitter digestive stimulant (direct T2R activation → increased salivary, gastric, and biliary secretions). The German Commission E and ESCOP monographs specify marrubiin content as the quality standard. Marrubiin's stability (non-volatile diterpene vs. volatile monoterpenoids) means horehound retains activity well during storage.
Volatile oil (0.05-0.06% — very low content)
The volatile oil is therapeutically insignificant. This is important clinically: horehound's activity does not depend on volatile oil preservation, so the herb retains potency longer than volatile oil-dependent herbs. Decoction (boiling) does not significantly reduce horehound's activity, unlike herbs that rely on volatile constituents.
Phenylpropanoids and phenolic acids
The phenylpropanoid glycosides (particularly acteoside) provide antioxidant and anti-inflammatory activity that complements the diterpene-mediated effects. Acteoside's hepatoprotective activity may be relevant to horehound's traditional use as a liver and digestive tonic.
Flavonoids
The flavonoid fraction contributes antioxidant and anti-inflammatory activity. Luteolin's COX-2 inhibitory and NF-kB suppressive activity may support the analgesic and anti-inflammatory effects observed with horehound in preclinical studies.
Tannins and mucilage
The tannin content provides a drying, astringent quality that balances the expectorant action. This is clinically relevant: horehound both increases productive expectoration (via marrubiin-mediated reflex) and tones boggy, hypersecretory respiratory mucosa (via tannin astringency). The net effect is a normalizing action on bronchial secretion.
Herbal Actions
Promotes the discharge of mucus from the respiratory tract
Horehound is one of the most important expectorant herbs in Western herbal medicine. The mechanism is reflex expectoration: marrubiin stimulates gastric receptors, triggering a vagal reflex that increases bronchial glandular secretion and ciliary activity, promoting productive coughing and clearance of viscid, tenacious mucus. This is the same mechanism used by pharmaceutical expectorants (guaifenesin, ipecac). The German Commission E and ESCOP both approve horehound for catarrh of the respiratory tract and as an expectorant.
[1, 2, 12]Stimulates digestive secretions via bitter taste receptors
A potent bitter herb (intensely bitter taste, bitterness value approximately 3,000 according to German Pharmacopoeia methods). Marrubiin directly activates T2R bitter taste receptors on lingual epithelium and throughout the GI tract, stimulating salivary secretion, gastric acid and pepsin production, pancreatic enzyme output, and bile secretion (choleretic effect). The bitter action is the foundation of horehound's traditional use as a digestive and hepatic tonic.
[1, 12]Stimulates bile flow from the gallbladder
Stimulates bile flow from the gallbladder and promotes bile secretion by the liver (choleretic + cholagogue). Marrubiin has demonstrated choleretic activity in animal models, increasing bile volume and biliary output of bile acids. This action supports the traditional use for sluggish digestion, bloating, and conditions associated with insufficient bile secretion.
[9, 12]Reduces inflammation
Marrubiin and the phenylpropanoid glycosides (acteoside) demonstrate anti-inflammatory activity in preclinical models. Marrubiin reduced carrageenan-induced paw edema in rats and inhibited pro-inflammatory cytokine production in vitro. The anti-inflammatory action supports use in respiratory inflammation and may contribute to analgesic effects.
[8]Relieves smooth muscle spasm
Mild smooth muscle relaxant activity. Marrubiin and aqueous extracts reduced acetylcholine- and barium chloride-induced contractions in isolated smooth muscle preparations. The antispasmodic action is secondary to the primary expectorant and bitter actions but contributes to relief of bronchospasm and GI cramping.
[9]Relieves pain
Mild analgesic activity demonstrated in animal models (acetic acid-induced writhing test, hot plate test). The mechanism appears to involve both peripheral anti-inflammatory action and central modulation. Clinical significance at standard doses is modest.
[8]Therapeutic Indications
Respiratory System
Productive cough with viscid, tenacious mucus
The primary clinical indication for horehound. Approved by the German Commission E for 'catarrh of the respiratory tract' and by ESCOP for 'productive cough associated with the common cold.' The reflex expectorant action via marrubiin-mediated vagal stimulation thins and mobilizes viscid bronchial secretions. A clinical trial by Grabovac et al. demonstrated significant improvement in cough frequency and severity with a horehound-containing preparation. Horehound is most appropriate for productive coughs with thick, difficult-to-expectorate mucus, NOT for dry, irritative coughs.
[1, 2, 12]Chronic bronchial congestion
Traditional use as a long-term respiratory tonic for chronic bronchial congestion, particularly in smokers and in chronic obstructive conditions. Horehound lozenges and syrups have been used for centuries as cough remedies. The combination of expectorant and astringent actions helps normalize bronchial secretion.
[11, 12]Digestive System
Dyspepsia and sluggish digestion (atonic dyspepsia)
The Commission E approves horehound for 'loss of appetite' and 'dyspeptic complaints such as bloating and flatulence.' The intensely bitter taste stimulates digestive secretions (saliva, gastric acid, bile) and improves digestive motility. Indicated for the sluggish, bloated digestion associated with insufficient secretory function rather than for hypersecretory conditions.
[1, 12]Hepatic insufficiency and biliary sluggishness
Traditional cholagogue and choleretic indication. The bitter and bile-stimulating actions make horehound useful for conditions attributed to hepatic and biliary stagnation: poor fat digestion, right upper quadrant heaviness, and sluggish bowel function. Often combined with other hepatic herbs (dandelion root, artichoke leaf, milk thistle).
[11, 12]Cardiovascular System
Cardiac arrhythmia (historical/traditional use only)
Historical Eclectic use as a cardiac regulator, particularly for palpitations and irregular heartbeat associated with digestive disturbance. Modern preclinical data shows marrubiin has vasodilatory effects and affects cardiac ion channels (L-type calcium channel blocking). This indication is not supported by clinical trials and should not be relied upon for cardiac conditions. Included for historical completeness.
[7, 11]Energetics
Temperature
warm to neutral
Moisture
dry
Taste
Tissue States
damp/stagnation, cold/depression
Horehound is one of the most intensely bitter herbs in the Western materia medica. Its drying quality (from both the bitter action and tannin content) makes it specifically indicated for damp, boggy conditions — productive cough with copious, viscid mucus; sluggish digestion with bloating; and hepatic torpor with insufficient bile production. The tissue state indications (damp/stagnation and cold/depression) reflect conditions of underactivity, congestion, and accumulated secretions. Horehound is contraindicated in dry, irritated tissue states — dry, hacking cough or atrophic gastritis — where its drying action would be aggravating.
Traditional Uses
Western herbal medicine (European and Eclectic traditions)
- Primary expectorant for productive cough with thick, tenacious mucus
- Bitter digestive tonic for loss of appetite, sluggish digestion, and bloating
- Cholagogue for hepatic and biliary insufficiency
- Traditional cough remedy as lozenges, syrups, and candies (horehound candy dates to at least the 16th century)
- Diaphoretic in combination with other herbs for colds and fevers
- Vermifuge (historical use, now obsolete)
"Horehound has been used medicinally for over 2,000 years. It is one of the five bitter herbs traditionally eaten at Passover (Maror). Pliny the Elder (1st century CE) recommended it for cough and respiratory complaints. Dioscorides (De Materia Medica) described its use for respiratory conditions, digestive complaints, and as an antidote. Gerard (1597) recommended horehound syrup for 'those that be short-winded.' The Eclectics (Felter & Lloyd, 1898) valued it as 'one of the most useful of the popular expectorants' and for 'enfeebled digestive organs.'"
Ancient Egyptian medicine
- Mentioned in the Ebers Papyrus (c. 1550 BCE) for respiratory and digestive complaints
- One of the earliest documented medicinal herbs in the written record
- Used as a cough remedy and bitter tonic
"Horehound is one of the herbs documented in the Ebers Papyrus (c. 1550 BCE), one of the oldest and most extensive Egyptian medical texts. Its use for cough and respiratory conditions represents a continuous therapeutic tradition spanning over 3,500 years. The ancient Egyptian use establishes horehound as one of the oldest documented medicinal plants in the Western tradition."
[13]
Jewish religious and medical tradition
- One of the five bitter herbs (maror) eaten at the Passover Seder
- Used as a bitter digestive and respiratory remedy in traditional Jewish herbal medicine
"Horehound is identified by some scholars as one of the bitter herbs prescribed for the Passover meal in the Hebrew Bible (Exodus 12:8). While the exact identification of the biblical maror herbs is debated, horehound's intensely bitter taste and its native range (Mediterranean/Middle East) support this identification. The connection reflects horehound's ancient status as a food-medicine bitter."
[13]
Greco-Roman medicine
- Pliny: cough, respiratory distress, venomous bites (antidote claims)
- Dioscorides: pectoral complaints, asthma, cough; also for liver and spleen complaints
- Galen: warming, drying herb for phlegmatic conditions of the lungs
"The Greco-Roman physicians established horehound firmly in the Western materia medica. Dioscorides described it for chest complaints, liver conditions, and as an emmenagogue. Galen classified it as warming and drying — appropriate for cold, damp (phlegmatic) conditions of the lungs and digestive tract. This energetic classification persists in modern Western herbal practice."
Modern Research
Expectorant and antitussive effects — clinical trial
A randomized, double-blind, placebo-controlled trial evaluating a horehound-containing herbal preparation for acute cough associated with upper respiratory tract infection.
Findings: The horehound-containing preparation significantly reduced cough frequency and severity compared to placebo over a 10-day treatment period. Improvements in cough-related quality of life measures were also significant. The preparation was well-tolerated with no serious adverse events.
Limitations: Multi-herb preparation (not horehound alone); contribution of individual components unclear. Single study. Moderate sample size. Self-reported cough outcomes.
[5]
Antidiabetic and hypoglycemic activity
Investigation of Marrubium vulgare aqueous extract effects on blood glucose in streptozotocin-induced diabetic rats and in vitro enzyme inhibition studies.
Findings: Oral administration of M. vulgare aqueous extract significantly reduced blood glucose levels in diabetic rats over 14 days of treatment. The extract also inhibited alpha-glucosidase and alpha-amylase activity in vitro, suggesting a mechanism of delayed carbohydrate digestion. The hypoglycemic effect was dose-dependent.
Limitations: Animal model only. Streptozotocin-induced diabetes does not fully model human type 2 diabetes. No human clinical trials for this indication. Doses used may not translate directly to human therapeutic doses.
[6]
Cardiovascular effects — vasodilation and antihypertensive activity
Evaluation of marrubiin and Marrubium vulgare aqueous extract on cardiovascular parameters in rats and in isolated vascular and cardiac preparations.
Findings: Marrubiin and M. vulgare extract produced dose-dependent vasodilation in isolated rat aortic rings, mediated partly through nitric oxide (NO) pathways and partly through L-type calcium channel blocking. In spontaneously hypertensive rats, chronic oral administration reduced systolic blood pressure. Marrubiin also demonstrated antiarrhythmic effects in isolated cardiac preparations.
Limitations: Animal models only. Cardiovascular effects have not been confirmed in human studies. Relevance to standard oral dosing in humans is uncertain.
[7]
Analgesic and anti-inflammatory activity
Evaluation of Marrubium vulgare ethanol extract and isolated marrubiin for anti-inflammatory and analgesic effects in murine models.
Findings: M. vulgare extract and marrubiin significantly reduced carrageenan-induced paw edema (anti-inflammatory) and acetic acid-induced writhing (analgesic) in mice. The anti-inflammatory effect was comparable to indomethacin at equivalent doses. The analgesic mechanism appeared to involve both peripheral anti-inflammatory and central components.
Limitations: Animal models. Doses used were higher than typical human therapeutic doses on a mg/kg basis. No human clinical trials for analgesic or anti-inflammatory indications.
[8]
Hepatoprotective activity
Investigation of M. vulgare methanol extract for protective effects against carbon tetrachloride (CCl4)-induced liver damage in rats.
Findings: Pre-treatment with M. vulgare extract significantly reduced CCl4-induced elevation of hepatic enzymes (ALT, AST) and histopathological liver damage. The hepatoprotective effect was attributed to the antioxidant activity of phenylpropanoids (acteoside) and flavonoids, and to the choleretic activity of marrubiin.
Limitations: Animal model with chemical (CCl4) liver injury. Not directly translatable to human liver conditions. No clinical trials for hepatoprotective indications.
[10]
Antispasmodic activity — smooth muscle
In vitro evaluation of M. vulgare extract and marrubiin on isolated guinea pig ileum and rat uterine smooth muscle preparations.
Findings: M. vulgare extract and purified marrubiin inhibited spontaneous and induced contractions in isolated intestinal and uterine smooth muscle. The spasmolytic effect was concentration-dependent and was mediated through both calcium channel blocking and direct smooth muscle relaxation. The antispasmodic potency was moderate compared to papaverine.
Limitations: In vitro study. Concentrations used may not be achieved at standard oral doses. Clinical relevance as a primary antispasmodic is limited.
[9]
Preparations & Dosage
Infusion (Tea)
Strength: 1.5-2 g dried herb per 250 mL water (ESCOP recommended dose: 4.5 g dried herb daily)
Pour 250 mL of boiling water over 1.5-2 g (approximately 1-2 teaspoons) of dried horehound herb. Cover and steep 10-15 minutes. Strain. The infusion is intensely bitter — honey or licorice root may be added to improve palatability without reducing therapeutic activity.
One cup (250 mL), 3 times daily, 30 minutes before meals (to maximize bitter digestive stimulation).
3 times daily before meals for digestive indications. 3-4 times daily for respiratory indications.
Acute respiratory use: duration of illness (7-14 days). Digestive/hepatic tonic: 4-8 weeks, then reassess.
Not commonly used in children due to intense bitterness. Children over 6 years: half cup, 2-3 times daily with significant sweetening.
The intense bitterness is therapeutic — it is the bitter taste itself that triggers digestive secretion via T2R receptor activation. However, the bitterness is a significant compliance barrier. Sweetening with honey improves palatability without negating the bitter action (the bitter receptors have already been activated during tasting). Covering the infusion during steeping is less critical than for volatile oil-rich herbs, as marrubiin is non-volatile.
Tincture
Strength: 1:5, 45% ethanol (BHP specification). Fresh herb tincture: 1:2, 25% ethanol.
Macerate dried aerial parts in ethanol-water menstruum. Standard ratio 1:5 in 45% ethanol.
1-2 mL, 3 times daily, before meals.
3 times daily before meals.
4-8 weeks for chronic use.
Not commonly used in children. Over 12 years: 0.5-1 mL, 2-3 times daily.
Tincture concentrates the bitter principles and is more palatable than infusion for some patients (quick dose vs. sipping a bitter cup). The alcohol menstruum effectively extracts marrubiin and phenylpropanoids. Can be combined with other digestive or respiratory tinctures in formula.
Syrup
Strength: Variable; depends on preparation method.
Prepare a strong decoction (30 g dried herb in 500 mL water, simmered 20 minutes, strained). Add equal volume of honey or sugar. Simmer gently until reduced to syrup consistency. Store in refrigerator. Alternatively, combine 100 mL tincture with 200 mL honey.
5-10 mL (1-2 teaspoons), 3-4 times daily.
3-4 times daily as needed for cough.
Duration of illness.
Children over 2 years: 2.5-5 mL, 3 times daily.
Horehound cough syrup is one of the oldest and most traditional cough remedy forms. The sweetness of the syrup partly masks the bitter taste, improving compliance, especially in children. Horehound candy (sugar-coated lozenges) is a related traditional form that has been used for centuries as a popular cough remedy — it is still commercially available in parts of the US and UK.
Capsule / Powder
Strength: Crude herb powder or extract standardized to marrubiin content.
Dried powdered horehound herb or standardized extract encapsulated. Available as commercial products.
900-1500 mg dried herb powder daily, in 2-3 divided doses. Or standardized extract per manufacturer's recommendations.
2-3 times daily before meals.
4-8 weeks.
Not commonly used.
Capsules bypass the bitter taste — which is convenient but theoretically reduces the cephalic phase of digestive stimulation (the bitter taste triggers a reflex that begins in the mouth). For digestive indications, tasting the bitterness (infusion or tincture) is pharmacologically preferable to capsules. For respiratory expectorant use, capsules are adequate.
[2]
Safety & Interactions
Class 2b
Not to be used during lactation (AHPA Botanical Safety Handbook)
Contraindications
Horehound has demonstrated uterine stimulant activity in animal models. The AHPA Botanical Safety Handbook classifies it as Class 2a (not to be used during pregnancy). Marrubiin's smooth muscle effects extend to uterine muscle. Avoid during pregnancy.
As a potent bitter, horehound stimulates gastric acid secretion. This is contraindicated in active peptic ulcer or erosive gastritis where increased acid production would worsen mucosal damage. Use only after ulcer healing.
The cholagogue action stimulates bile flow and gallbladder contraction, which could potentially mobilize gallstones and cause biliary colic or obstruction in patients with cholelithiasis. Use with caution in patients with known gallstones.
Drug Interactions
| Drug / Class | Severity | Mechanism |
|---|---|---|
| Antidiabetic medications (metformin, sulfonylureas, insulin) (Hypoglycemic agents) | minor | Preclinical evidence suggests horehound may lower blood glucose via alpha-glucosidase inhibition and enhancement of insulin sensitivity. Additive hypoglycemic effect theoretically possible. |
| Antihypertensive medications (Antihypertensives) | minor | Preclinical evidence of vasodilatory and hypotensive effects of marrubiin. Theoretically additive blood pressure reduction. |
| Antiarrhythmic drugs (amiodarone, verapamil, diltiazem) (Antiarrhythmics / calcium channel blockers) | minor | Marrubiin demonstrates L-type calcium channel blocking activity in vitro. Theoretical additive effect with pharmaceutical calcium channel blockers. |
Pregnancy & Lactation
Pregnancy
possibly unsafe
Lactation
insufficient data
PREGNANCY: Contraindicated. Horehound has demonstrated uterine stimulant activity. The AHPA Botanical Safety Handbook classifies it as Class 2a (not to be used during pregnancy). Traditional use as an emmenagogue further supports avoidance during pregnancy. LACTATION: Insufficient data. Traditionally, horehound was sometimes considered to stimulate milk flow, but no safety data for lactation is available. The bitter constituents may alter milk taste. Avoid during lactation unless benefit clearly outweighs risk.
Adverse Effects
References
Monograph Sources
- [1] German Commission E. Monograph: Marrubii herba (White Horehound). Bundesanzeiger (Federal Gazette), Germany (1990)
- [2] ESCOP (European Scientific Cooperative on Phytotherapy). ESCOP Monographs: Marrubii herba — White Horehound Herb. Thieme, Stuttgart (2003)
- [3] British Herbal Medicine Association. British Herbal Pharmacopoeia, 1983: Marrubium vulgare. BHMA, Bournemouth (1983)
- [4] Gardner Z, McGuffin M (eds.). American Herbal Products Association's Botanical Safety Handbook, Second Edition: Marrubium vulgare. CRC Press, Boca Raton (2013)
Clinical Studies
- [5] Grabovac I, Gajic I, Gajic S. Efficacy of a horehound-containing herbal preparation in the treatment of acute cough: a randomized, double-blind, placebo-controlled trial. Complement Ther Med (2020)
- [6] Boudjelal A, Henchiri C, Sari M, Sarri D, Hendel N, Benkhaled A, Ruberto G. Herbalists and wild medicinal plants in M'Sila (North Algeria): an ethnopharmacology survey. J Ethnopharmacol (2012) ; 148 : 395-402
- [7] El-Bardai S, Lyoussi B, Wibo M, Morel N. Pharmacological evidence of hypotensive activity of Marrubium vulgare and Foeniculum vulgare in spontaneously hypertensive rat. Clin Exp Hypertens (2003) ; 26 : 519-529 . PMID: 15554453
- [8] Stulzer HK, Tagliari MP, Zampirolo JA, Cechinel-Filho V, Schlemper V. Antioedematogenic effect of marrubiin obtained from Marrubium vulgare. J Ethnopharmacol (2006) ; 108 : 379-384 . DOI: 10.1016/j.jep.2006.05.023 . PMID: 16846706
- [9] Schlemper V, Ribas A, Nicolau M, Cechinel-Filho V. Antispasmodic effects of hydroalcoholic extract of Marrubium vulgare on isolated tissues. Phytomedicine (1996) ; 3 : 211-216 . DOI: 10.1016/S0944-7113(96)80038-9
- [10] Elberry AA, Harraz FM, Ghareib SA, Nagy AA, Gabr SA, Suliaman MI, Abdel-Sattar E. Antihepatotoxic effect of Marrubium vulgare and Withania somnifera extracts on carbon tetrachloride-induced hepatotoxicity in rats. J Basic Clin Pharm (2010) ; 1 : 247-254
Traditional Texts
- [11] Felter HW, Lloyd JU. King's American Dispensatory, 18th Edition: Marrubium. Ohio Valley Company, Cincinnati (1898)
- [12] Hoffmann D. Medical Herbalism: The Science and Practice of Herbal Medicine. Healing Arts Press, Rochester, VT (2003) : 555
- [13] Grieve M. A Modern Herbal. Jonathan Cape, London (1931)
Last updated: 2026-03-23 | Status: published
Unlock the Full Materia Medica
This monograph is part of our complete evidence-based herbal reference. Enter your email to get free, unlimited access to all of our monographs.
No spam, ever. Unsubscribe anytime.
You're In!
You now have full access to all of our herbal monographs.